NCT07199868View on ClinicalTrials.gov

The Role of Ovarian PRP Therapy in Poseidon Poor Responders Women Undergoing ICSI Cycle

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Poor Ovarian ReservePlatelet Derived Growth Factor
Interventions
PROCEDURE

During early-mid follicular phase, using TV-US guidance and conscious sedation, 1.5 ml of PRP was injected into each ovary's subcortical layer using a 17-gauge ovum pick-up needle.

During early-mid follicular phase, using TV-US guidance and conscious sedation, 1.5 ml of PRP was injected into each ovary's subcortical layer using a 17-gauge ovum pick-up needle.

Trial Locations (2)

00964

Collage of medicine, Baghdad

Collage of medicine, Karbala

All Listed Sponsors
lead

Karbala University

OTHER

NCT07199868 - The Role of Ovarian PRP Therapy in Poseidon Poor Responders Women Undergoing ICSI Cycle | Biotech Hunter | Biotech Hunter